@StockChamp11 @javerick Not πŸ’― on why it appears to be kept below 75M mcap. From what we have seen the SP won't budge regardless of the PR. πŸ€·β€β™‚οΈπŸ€·β€β™‚οΈ I must bear in mind none of the PR provides any tangible value to the company but I would have expected to be sitting much higher than our 75Mcap ceiling. The recent data is a huge first step and lays a foundation for Kitov as a oncology' focused pharma company. Let's see what any new revelations reveal about our short term SP
  • 4